| 000 | 01895 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515111550.0 | ||
| 264 | 0 | _c20080317 | |
| 008 | 200803s 0 0 eng d | ||
| 022 | _a1365-3156 | ||
| 024 | 7 |
_a10.1111/j.1365-3156.2007.01991.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFerreira, Isabel D | |
| 245 | 0 | 0 |
_aPlasmodium falciparum from Pará state (Brazil) shows satisfactory in vitro response to artemisinin derivatives and absence of the S769N mutation in the SERCA-type PfATPase6. _h[electronic resource] |
| 260 |
_bTropical medicine & international health : TM & IH _cFeb 2008 |
||
| 300 |
_a199-207 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenosine Triphosphatases _xgenetics |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntimalarials _xpharmacology |
| 650 | 0 | 4 | _aArtemether |
| 650 | 0 | 4 |
_aArtemisinins _xpharmacology |
| 650 | 0 | 4 | _aArtesunate |
| 650 | 0 | 4 |
_aBrazil _xepidemiology |
| 650 | 0 | 4 | _aDrug Resistance |
| 650 | 0 | 4 | _aGene Dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMalaria, Falciparum _xepidemiology |
| 650 | 0 | 4 |
_aMultidrug Resistance-Associated Proteins _xgenetics |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aParasitic Sensitivity Tests |
| 650 | 0 | 4 |
_aPlasmodium falciparum _xdrug effects |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 | _aPolymorphism, Restriction Fragment Length |
| 650 | 0 | 4 |
_aProtozoan Proteins _xgenetics |
| 650 | 0 | 4 |
_aSesquiterpenes _xpharmacology |
| 700 | 1 | _aMartinelli, Axel | |
| 700 | 1 | _aRodrigues, Louise A | |
| 700 | 1 | _ado Carmo, Ediclei L | |
| 700 | 1 | _ado Rosário, Virgílio E | |
| 700 | 1 | _aPóvoa, Marinete M | |
| 700 | 1 | _aCravo, Pedro | |
| 773 | 0 |
_tTropical medicine & international health : TM & IH _gvol. 13 _gno. 2 _gp. 199-207 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-3156.2007.01991.x _zAvailable from publisher's website |
| 999 |
_c17807651 _d17807651 |
||